Viewing Study NCT02903966

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2026-02-25 @ 6:51 PM
Study NCT ID: NCT02903966
Status: COMPLETED
Last Update Posted: 2020-06-11
First Post: 2016-09-13
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: GSK2982772 Study in Subjects With Ulcerative Colitis
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colitis, Ulcerative View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tolerability View
None GSK2982772 View
None Safety View
None Pharmacokinetics View
None RIP1 kinase inhibitor View
None Ulcerative colitis View
None Pharmacodynamics View